ライフサイエンスコーパス: Pasteurella multocida

1 acteria including Haemophilus influenzae and Pasteurella multocida.

2 Haemophilus spp., Neisseria gonorrhoeae, and Pasteurella multocida.

3 5 from Haemophilus influenzae and Oma87 from Pasteurella multocida.

4 ia meningitidis, Haemophilus influenzae, and Pasteurella multocida.

5 nia pestis and the human and animal pathogen Pasteurella multocida.

6 tion of the pig's upper respiratory tract by Pasteurella multocida.

7 ely related species, Actinobacillus suis and Pasteurella multocida.

8 ilus influenzae, Neisseria meningitidis, and Pasteurella multocida.

9 Type A Pasteurella multocida, a prevalent animal pathogen, empl

10 l pathogens, including Haemophilus parasuis, Pasteurella multocida, Actinobacillus pleuropneumoniae,

11 c nonfastidious species were as follows: for Pasteurella multocida and staphylococci tested on Muelle

12 ents were conducted with a zoonotic pathogen Pasteurella multocida and the fluoroquinolone enrofloxac

13 Synechocystis sp., Deinococcus radiodurans, Pasteurella multocida, and Actinobacillus actinomycetemc

14 ose of Salmonella enterica, Vibrio cholerae, Pasteurella multocida, and Haemophilus influenzae.

15 zae, Proteus mirabilis, Vibrio fischeri, and Pasteurella multocida are all cleaved by RNase III as pr

16 Bordetella bronchiseptica and toxigenic Pasteurella multocida are the etiologic agents of swine

17 ly potent against the Gram-negative pathogen Pasteurella multocida both in vitro and in a mouse infec

18 eir potencies against the bacterial pathogen Pasteurella multocida both in vitro and in mouse infecti

19 The fowl cholera pathogen Pasteurella multocida Carter Type A also produces HA in

20 Fowl cholera, a disease caused by Pasteurella multocida, continues to be a major problem f

21 The pnhA gene of Pasteurella multocida encodes PnhA, which is a member of

22 oop sequences from Enterococcus faecalis and Pasteurella multocida gamma-GCS-GS, isoforms that are in

23 To identify Pasteurella multocida genes that are differentially expr

24 The Pasteurella multocida HA synthase, pmHAS, a polymerizing

25 gmented genomic DNA from the animal pathogen Pasteurella multocida has identified a gene encoding a p

26 P]UDP products made by the purified class II Pasteurella multocida HAS were not released by adding un

27 Outer membrane proteins (OMPs) of Pasteurella multocida have various functions related to

28 The Pasteurella multocida heparosan synthases, PmHS1 and PmH

29 The Pasteurella multocida hyaluronan synthase (PmHAS) cataly

30 tein, PfhB2, from the opportunistic pathogen Pasteurella multocida, in our analysis.

31 the literature, of ocular infections due to Pasteurella multocida include: endophtalmitis, keratitis

32 Pasteurella multocida is a bacterial pathogen that cause

33 Pasteurella multocida is a mucosal pathogen that coloniz

34 Pasteurella multocida is a rare cause of neonatal bacter

35 Pasteurella multocida is a small nonmotile gram-negative

36 Pasteurella multocida is a zoonotic Gram-negative cocco-

37 As infection with Pasteurella multocida is common in rabbits, an enzyme im

38 Pasteurella multocida is composed of three subspecies th

39 e rapid, accurate method to detect toxigenic Pasteurella multocida is needed for improved clinical di

40 The dermatonecrotic toxin produced by Pasteurella multocida is one of the most potent mitogeni

41 Pasteurella multocida is the causative agent of a wide r

42 Pasteurella multocida isolates with enrofloxacin MIC of

43 bacteria, including Haemophilus influenzae, Pasteurella multocida, Neisseria gonorrhoeae, Neisseria

44 se of rapidly evolving conjunctivitis due to Pasteurella multocida, occurring after direct inoculatio

45 enes encoding Haemophilus influenzae D15 and Pasteurella multocida Oma87 protective outer membrane an

46 e genome sequence of a common avian clone of Pasteurella multocida, Pm70.

47 an synthases from the Gram-negative bacteria Pasteurella multocida, PmHS1 and PmHS2, were efficiently

48 The intracellularly acting protein toxin of Pasteurella multocida (PMT) causes numerous effects in c

49 hase, PmCS, from the Gram-negative bacterium Pasteurella multocida polymerize the glycosaminoglycan (

50 Toxigenic strains of Pasteurella multocida produce a 146 kDa toxin (PMT) that

51 isolates and 4 attenuated vaccine strains of Pasteurella multocida recovered from multiple avian spec

52 We present a case of fulminant Pasteurella multocida sepsis in a 66-year-old man who ha

53 Neuraminidases produced by 16 strains of Pasteurella multocida (serotypes 1 to 16) were character

54 Fowl cholera is caused by Pasteurella multocida serovars A:1, A:3, and A:4.

55 -ray crystal structures of a multifunctional Pasteurella multocida sialyltransferase (Delta24PmST1) w

56 he structures of a truncated multifunctional Pasteurella multocida sialyltransferase (Delta24PmST1),

57 Pasteurella multocida strains isolated from 15 pigs with

58 ntical for P. multocida subsp. multocida and Pasteurella multocida subsp. gallicida but differs from

59 e more than 17 species of Pasteurella known, Pasteurella multocida subsp. multocida and Pasteurella m

60 Pasteurella multocida subsp. multocida is a commensal an

61 , Pasteurella multocida subsp. multocida and Pasteurella multocida subsp. septica are among the most

62 mediates adhesion of serogroup A strains of Pasteurella multocida to elicited turkey air sac macroph

63 as assessed by exposing broth suspensions of Pasteurella multocida to perflubron for various times.

64 agonists and phospholipase C is activated by Pasteurella multocida toxin (a G(q) alpha-subunit agonis

65 We have shown that Pasteurella multocida toxin (PMT) directly causes transi

66 Pasteurella multocida toxin (PMT) has been hypothesized

67 Pasteurella multocida toxin (PMT) is a potent mitogen fo

68 Pasteurella multocida toxin (PMT) is a potent mitogen kn

69 The Pasteurella multocida toxin (PMT) is a potent mitogen wh

70 atalytic and receptor-binding domains of the Pasteurella multocida toxin (PMT) were investigated.

71 not obvious and is explored with recombinant Pasteurella multocida toxin (rPMT, a Galpha(q) agonist).

72 ion on its own, it potentiated the effect of Pasteurella multocida toxin by 2-fold and ionomycin by 3

73 quires protein kinase C and MEK activity) by Pasteurella multocida toxin, a Galpha(q) agonist that pr

74 er these conditions, treatment of cells with Pasteurella multocida toxin, a selective inhibitor of Ga

75 channel current inhibition was diminished by Pasteurella multocida toxin, mimicked by constitutively

76 These include Pasteurella multocida toxin, which uniquely acts as a mi

77 otein ChaN, and an uncharacterized domain of Pasteurella multocida toxin.

78 ogous to the membrane targeting C1 domain of Pasteurella multocida toxin.

79 des tryptophanase; as well as a homologue of Pasteurella multocida tsaA, which encodes an alkyl perox

80 in a single polypeptide as was found for the Pasteurella multocida Type A PmHAS, the hyaluronan synth

81 Heparosan synthase 1 (PmHS1) from Pasteurella multocida Type D is a dual action glycosyltr

82 Pasteurella multocida Type D, a causative agent of atrop

83 noculated intranasally with 9 x 10(7) CFU of Pasteurella multocida type D.

84 Pasteurella multocida Type F, the minor fowl cholera pat

85 The extracellular polysaccharide capsules of Pasteurella multocida types A, D, and F are composed of

86 ue of the NeuA C-terminal domain (Pm1710) in Pasteurella multocida was also shown to be an esterase,

87 Pasteurella multocida was grown in iron-free chemically

88 ytica and three matched pairs of isolates of Pasteurella multocida were isolated by using a nasal swa

89 The major outer membrane protein (OmpH) of Pasteurella multocida X-73 was purified by selective ext